Evotec AG
Schnackenburgallee 114
D-22525 Hamburg
Germany
Tel: +49 (0)40 560 81-0
Fax: +49 (0)40 560 81-222
|
|
With high quality capabilities for successful chemical and pharmaceutical development Evotec provides an integrated platform which addresses our partners needs from pre-clinical development to commercial manufacture. The platform integrates world-class capabilities in process research and development (PRD), custom preparation, scale-up and manufacturing (kilograms to tonnes), formulation and all supported by the very best in analytical and regulatory compliance.
Further Information: http://www.evotec.com
Related news from our archive
Evotec Achieves Certificate of GMP Compliance from MHRA
This replaces the old statement of cGMP compliance previously issued.
CHDI Selects Evotec as Strategic Drug Discovery Partner in the Search for Huntington Disease Treatments
Four contracts signed since March 2006 covering most of Evotec’s drug discovery capability.
University of Cincinnati and Cincinnati Children's Hospital Medical Center Partner with Evotec
The Computational Medicine Center (CMC), an Ohio Third Frontier-funded research collaboration between Cincinnati Children's and UC, has purchased Evotec Technologies' ultra-High-Throughput Screening (uHTS) system.